From: A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
Group
First dose (µg/kg) 30–60 min before surgery
Second dose (µg/kg) 24 h after surgery
Total dose (µg/kg)
1
0.25
0.5
2
1.0
3
0.75
1.25
4
1.5
5
2.0